http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f083c261d6416c250bb7fcc8c550b6d8
Outgoing Links
Predicate | Object |
---|---|
family-name | Fernyhough |
name | Paul Fernyhough |
given-name | Paul |
organization-name | Division of Neurodegenerative Disorders, St Boniface Hospital Albrechtsen Research Centre, Winnipeg, MB, Canada; Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB, Canada Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada; Division of Neurodegenerative Disorders, St Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada. Electronic address: paulfernyhough@yahoo.com. School of Biological Sciences, University of Manchester, Manchester M13 9PT, United Kingdom. St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, Manitoba, Canada; Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada School of Biological Sciences, University of Manchester, Manchester, U.K Division of Neurodegenerative Disorders, St Boniface Hospital Research Centre, Winnipeg, MB, Canada R2H 2A6; Department of Pharmacology & Therapeutics, University of Manitoba, Winnipeg, MB, Canada R3E 0T6 Division of Neurodegenerative Disorders, St. Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada;; Department of Pharmacology and Therapeutics, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. Division of Neurodegenerative Disorders, St. Boniface Hospital Research Centre, Winnipeg, Canada; Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Canada Division of Neurodegenerative Disorders, St Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada;; Department of Pharmacology & Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada. Department of Pharmacology, St. Bartholomew’s and the Royal London School of Medicine and Dentistry, Queen Mary and Westfield College, University of London Department of Pharmacology and Therapeutics and Division of Neurodegenerative Disorders, St. Boniface Research Center, University of Manitoba, Winnipeg, Manitoba R2H 2A6, Canada Department of Pharmacology, Queen Mary and Westfield College London, U.K Division of Neurodegenerative Disorders, St Boniface Hospital Research Centre and Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada Department of Physiology and Pathophysiology,; Department of Pharmacology and Therapeutics, Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre, University of Manitoba, Winnipeg, MB, Canada R2H 2H6; and Division of Neurodegenerative Disorders, St. Boniface Hospital Research Centre, Winnipeg, MB, Canada, R2H 2A6; Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, MB, Canada, R3E 0W3 Division of Neurodegenerative Disorders, St. Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada;; Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada; St. Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada;; Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Pharmacology and Therapeutics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada; Division of Neurodegenerative Disorders, St. Boniface Hospital Albrechtsen Research Centre, Winnipeg, Canada Division of Neurodegenerative Disorders, St. Boniface Hospital Research Centre, Winnipeg, Manitoba, Canada; Department of Pharmacology and Therapeutics, University of Manitoba, Winnipeg, Manitoba, Canada |
Incoming Links
Total number of triples: 113.